This webinar from the "Moving from Hepatitis Discovery to Elimination: NIH Research Advancing Hepatitis Elimination" series was hosted by the National Institute on Drug Abuse. Speakers discussed collaborative research on hepatitis C networks among persons who inject drugs, using peers and technology to increase uptake of HCV screening and treatment, and hepatitis C elimination among persons injecting drugs in Mexico during the COVID-19 pandemic.

Presentations included:

• Dr. Todd Allen, Professor of Medicine, Harvard Medical School | Collaborative research on Hepatitis C networks among persons who inject drugs using next generation genetic sequencing technology
• Dr. Todd Korthuis, Professor of Medicine, Oregon Health Sciences University | Using peers and technology to increase uptake of HCV screening & treatment and substance use disorder treatment among people who use drugs in rural Oregon
• Dr. Natasha K. Martin, Professor of Medicine, University of California San Diego |  HCV elimination among PWID in rural settings: insights from epidemic modeling and observational data in Mexico

A round-table discussion followed with comments from:

• Holly Hagan PhD, MPH; Director, NIDA P30 Center for Drug Use and HIV|HCV Research at Global Public Health; Professor, NYU School of Global Public Health
• Yngvild K. Olsen MD, MPH; Director of the Center for Substance Abuse Treatment (CSAT); SAMHSA
• Eyasu Teshale, MD: Division of Viral Hepatitis; CDC
• Carolyn Wester MD, MPH; Director, Division of Viral Hepatitis; CDC